Multispecifics & Other Modalities

The Undruggable Podcast

Hosted by Ray Deshaies

Senior Vice President, Global Research at Amgen

Beginning with the introduction of aspirin at the start of the 20th century, there have been three major waves of innovation in drug discovery. Science has made incredible breakthroughs in treating and curing disease, and yet 85% of disease targets are still considered undruggable, which represents an ongoing barrier to discovering medicines for complex diseases like cancer and autoimmune conditions.

In this five-part series, Ray Deshaies, who has spent decades in academic research and is a senior vice president of Global Research at Amgen, hosts conversations with leading scientists to take a deep dive into the most promising new innovations to treat disease as we enter a fourth wave of innovation.

Listen in to learn how the current wave of discovery, led by new types of multispecific medicines, has the potential to radically alter our concept of how drugs can work and pave the way for new solutions.

Listen Here